Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07137286 · ClinicalTrials.gov registry record
A Study of Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet
A clinical trial of LDL Hyper-responsiveness, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07137286: Recruiting study of LDL Hyper-responsiveness, sponsored by Mayo Clinic.
NCT07137286 is a study of LDL Hyper-responsiveness that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07137286, a study of LDL Hyper-responsiveness, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify whether individuals following a ketogenic diet who experience extreme LDL-C elevation, termed "hyper-responders", have identifiable genetic variations in genes involved in cholesterol absorption.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07137286
The ClinicalTrials.gov registry entry for NCT07137286 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with LDL Hyper-responsiveness appearing as the primary indexed condition, and to 0 interventions.
NCT07137286 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07137286 about?
NCT07137286 is a clinical study titled "A Study of Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet". The purpose of this study is to identify whether individuals following a ketogenic diet who experience extreme LDL-C elevation, termed "hyper-responders", have identifiable genetic variations in genes involved in cholesterol absorption.
What is the current status of trial NCT07137286?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-09-11. Estimated completion is 2027-08.
What conditions does trial NCT07137286 study?
This clinical trial studies the following conditions: LDL Hyper-responsiveness.
Who is sponsoring clinical trial NCT07137286?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07137286 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.